Mark L Baum - Net Worth and Insider Trading
Mark L Baum Net Worth
The estimated net worth of Mark L Baum is at least $28 Million dollars as of 2024-05-13. Mark L Baum is the CHIEF EXECUTIVE OFFICER of Harrow Inc and owns about 2,137,525 shares of Harrow Inc (HROW) stock worth over $25 Million. Mark L Baum is the Director of Eton Pharmaceuticals Inc and owns about 794,745 shares of Eton Pharmaceuticals Inc (ETON) stock worth over $3 Million. Mark L Baum is also the Director of Ideal Power Inc and owns about 2,906 shares of Ideal Power Inc (IPWR) stock worth over $21,795. Details can be seen in Mark L Baum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark L Baum has not made any transactions after 2024-03-22 and currently still holds the listed stock(s).
Transaction Summary of Mark L Baum
Mark L Baum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark L Baum owns 6 companies in total, including Harrow Inc (HROW) , Eton Pharmaceuticals Inc (ETON) , and Ideal Power Inc (IPWR) among others .
Click here to see the complete history of Mark L Baum’s form 4 insider trades.
Insider Ownership Summary of Mark L Baum
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HROW | Harrow Inc | 2024-03-22 | director & 10 percent owner & Chief Executive Officer |
ETON | Eton Pharmaceuticals Inc | 2018-11-15 | director |
IPWR | Ideal Power Inc | 2017-03-03 | director |
2007-05-28 | director & President | ||
2006-10-03 | other: General Counsel | ||
2003-12-20 | director & 10 percent owner & CEO |
Mark L Baum Latest Holdings Summary
Mark L Baum currently owns a total of 3 stocks. Among these stocks, Mark L Baum owns 2,137,525 shares of Harrow Inc (HROW) as of March 22, 2024, with a value of $25 Million and a weighting of 90.02%. Mark L Baum owns 794,745 shares of Eton Pharmaceuticals Inc (ETON) as of November 15, 2018, with a value of $3 Million and a weighting of 9.9%. Mark L Baum also owns 2,906 shares of Ideal Power Inc (IPWR) as of March 3, 2017, with a value of $21,795 and a weighting of 0.08%.
Latest Holdings of Mark L Baum
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HROW | Harrow Inc | 2024-03-22 | 2,137,525 | 11.60 | 24,795,290 |
ETON | Eton Pharmaceuticals Inc | 2018-11-15 | 794,745 | 3.43 | 2,725,975 |
IPWR | Ideal Power Inc | 2017-03-03 | 2,906 | 7.50 | 21,795 |
Holding Weightings of Mark L Baum
Mark L Baum Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark L Baum has made a total of 4 transactions in Harrow Inc (HROW) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Harrow Inc is the acquisition of 9,000 shares on March 22, 2024, which cost Mark L Baum around $104,310.
According to the SEC Form 4 filings, Mark L Baum has made a total of 0 transactions in Eton Pharmaceuticals Inc (ETON) over the past 5 years. The most-recent trade in Eton Pharmaceuticals Inc is the acquisition of 10,000 shares on November 15, 2018, which cost Mark L Baum around $60,000.
According to the SEC Form 4 filings, Mark L Baum has made a total of 0 transactions in Ideal Power Inc (IPWR) over the past 5 years. The most-recent trade in Ideal Power Inc is the acquisition of 780 shares on March 3, 2017, which cost Mark L Baum around $19,812.
Insider Trading History of Mark L Baum
- 1
Mark L Baum Trading Performance
GuruFocus tracks the stock performance after each of Mark L Baum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark L Baum is 7.16%. GuruFocus also compares Mark L Baum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark L Baum within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark L Baum's insider trading performs compared to the benchmark.
Mark L Baum Ownership Network
Ownership Network List of Mark L Baum
Ownership Network Relation of Mark L Baum
Mark L Baum Owned Company Details
What does Harrow Inc do?
Who are the key executives at Harrow Inc?
Mark L Baum is the director & 10 percent owner & Chief Executive Officer of Harrow Inc. Other key executives at Harrow Inc include 10 percent owner Opaleye Management Inc. , VP & Accounting and Reporting Andrew Boll , and director & 10 percent owner & Chairman of the Board Robert J Kammer .
Harrow Inc (HROW) Insider Trades Summary
Over the past 18 months, Mark L Baum made 4 insider transaction in Harrow Inc (HROW) with a net purchase of 47,300. Other recent insider transactions involving Harrow Inc (HROW) include a net purchase of 646,183 shares made by Opaleye Management Inc. , a net purchase of 45,000 shares made by Martin A. Makary , and a net purchase of 2,500 shares made by Andrew Boll .
In summary, during the past 3 months, insiders sold 0 shares of Harrow Inc (HROW) in total and bought 179,000 shares, with a net purchase of 179,000 shares. During the past 18 months, 0 shares of Harrow Inc (HROW) were sold and 742,843 shares were bought by its insiders, resulting in a net purchase of 742,843 shares.
Harrow Inc (HROW)'s detailed insider trading history can be found in Insider Trading Tracker table.
Harrow Inc Insider Transactions
Mark L Baum Mailing Address
Above is the net worth, insider trading, and ownership report for Mark L Baum. You might contact Mark L Baum via mailing address: C/o Imprimis Pharmaceuticals, Inc, 12264 El Camino Real, Suite 350, San Diego Ca 92130.